Fludarabine Labelled with Fluor 18: A New Radiotracer for Onco-hematology
The CEA and Zionexa have signed an exclusive license agreement for Fludarabine labelled with Fluor 18 ([18F] Fludarabine), an innovative radiopharmaceutical.
ASCO19 Session “Meet the professors: Are we ready for prime time in Molecular Imaging in Breast Cancer?”
We are pleased to announce our participation in ASCO 2019 was a great success, and the keypoints of the ASCO session : “Are we ready for prime time in molecular imaging of breast cancer?".
Peter Webner’s Opinion on the Future of Molecular Imaging in DOTmed News
Discover Peter Webner's Opinion on the Future of Molecular Imaging in DOTmed News.
EANM 2019
Zionexa will be at EANM 2019 in Barcelona, Spain
